Economic Community (AEC), Thai capital market must be prompt for rapid change coming with wider business opportunity, economic growth and fierce competition. The SEC will keep close eyes on the development

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

customers and new customers expansion. PET bottle Segment Revenue from sales of PET bottle was 116.6 MB, an increase by 10.2 MB or 9.6% y-o-y mainly due to sales growth in existing customers and increase

economy has moved on a positive trajectory and has followed a similar pattern to the previous quarter of last year. Since the second half of 2017 growth has been driven by the manufacturing sector, which

of 1.4% Q-o-Q, but a reduction of approximately 2.7% Y-o-Y, while sales revenue in USD terms grew by 5.3% Q-o-Q and 7.7% Y-o-Y. The slight Sales growth in Baht terms was due to the THB's strengthening

the same period of 2017. Excluding TBSP of 16.9% GP, Company’s %GP represented at 24.1%, slightly growth primary by higher Gross Profit of Digital Print & Mail business. %Gross Profit Margin Mil THB 330

6.3 % increased from Year 2018 in Baht 175.5 million of which Baht 2,869.8 million was revenue from sales. The Company had successfully recorded a sales growth of Baht 162.2 million, or 6.0 % year-over

1Q17. The sales growth Y-o-Y was adversely impacted by 1) the THB's strengthening against the USD and EUR in the period, with the effect being about 2.7% on sales and 2) new selling prices that took

-o-Q by 1.7% from 2Q17. The sales growth Y-o-Y was adversely impacted by 1) the THB's strengthening against the USD in the period, with the effect being about 3.0% on sales and 2) new selling prices